Interleukin-18-mediated interferon-gamma secretion is regulated by thymosin beta 4 in human NK cells

Immunobiology

Volumn 216, Issue 10, 2011, Pages 1155-1162

  Lee, Ha reum ^a   Yoon, Sun Young ^a   Song, Seok Bean ^a   Park, Yoorim ^a   Kim, Tae Sung ^b   Kim, Seonghan ^c   Hur, Dae Young ^c   Song, Hyun Keun ^c   Park, Hyunjeong ^d   Cho, Daeho ^a  

^a Sookmyung Women's University   (South Korea)

^b Korea University   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

Interferon gamma; Interleukin 18; Natural killer cells; Thymosin beta 4

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 18; MITOGEN ACTIVATED PROTEIN KINASE P38; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; THYMOSIN BETA4;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INTERFERON PRODUCTION; INTRACELLULAR SIGNALING; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; UPREGULATION;

GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-18; KILLER CELLS, NATURAL; THYMOSIN;

EID: 80052100986     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.04.002     Document Type: Article

References (52)

1. Abrass C.K., Hansen K.M. Insulin-like growth factor binding protein-5-induced laminin {gamma}1 transcription requires filamin A. J. Biol. Chem. 2010.
2. Anton I.M., de la Fuente M.A., Sims T.N., Freeman S., Ramesh N., Hartwig J.H., Dustin M.L., Geha R.S. WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. Immunity 2002, 16:193.
3. Badamchian M., Fagarasan M.O., Danner R.L., Suffredini A.F., Damavandy H., Goldstein A.L. Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int. Immunopharmacol. 2003, 3:1225.
4. Barbulescu K., Becker C., Schlaak J.F., Schmitt E., Meyer zum Buschenfelde K.H., Neurath M.F. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. J. Immunol. 1998, 160:3642.
5. Biron C.A. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 1997, 9:24.
6. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 1999, 17:189.
7. Boncela J., Smolarczyk K., Wyroba E., Cierniewski C.S. Binding of PAI-1 to endothelial cells stimulated by thymosin beta4 and modulation of their fibrinolytic potential. J. Biol. Chem. 2006, 281:1066.
8. Brieger A., Plotz G., Zeuzem S., Trojan J. Thymosin beta 4 expression and nuclear transport are regulated by hMLH1. Biochem. Biophys. Res. Commun. 2007, 364:731.
9. Bryceson Y.T., March M.E., Ljunggren H.G., Long E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006, 107:159.
10. Cha H.J., Jeong M.J., Kleinman H.K. Role of thymosin beta4 in tumor metastasis and angiogenesis. J. Natl. Cancer Inst. 2003, 95:1674.
11. Crockford D. Development of thymosin beta4 for treatment of patients with ischemic heart disease. Ann. N. Y. Acad. Sci. 2007, 1112:385.
12. Dull T., Zufferey R., Kelly M., Mandel R.J., Nguyen M., Trono D., Naldini L. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 1998, 72:8463.
13. Fathallah-Shaykh H.M., Zhao L.J., Kafrouni A.I., Smith G.M., Forman J. Gene transfer of IFN-gamma into established brain tumors represses growth by antiangiogenesis. J. Immunol. 2000, 164:217.
14. Follenzi A., Ailles L.E., Bakovic S., Geuna M., Naldini L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 2000, 25:217.
15. Goldstein A.L., Slater F.D., White A. Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin). Proc. Natl. Acad. Sci. U. S. A. 1966, 56:1010.
16. Goldstein A.L., Hannappel E., Kleinman H.K. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol. Med. 2005, 11:421.
17. Golla R., Philp N., Safer D., Chintapalli J., Hoffman R., Collins L., Nachmias V.T. Co-ordinate regulation of the cytoskeleton in 3T3 cells overexpressing thymosin-beta4. Cell Motil. Cytoskeleton 1997, 38:187.
18. Hannappel E. Beta-Thymosins. Ann. N. Y. Acad. Sci. 2007, 1112:21.
19. Hyodo Y., Matsui K., Hayashi N., Tsutsui H., Kashiwamura S., Yamauchi H., Hiroishi K., Takeda K., Tagawa Y., Iwakura Y., Kayagaki N., Kurimoto M., Okamura H., Hada T., Yagita H., Akira S., Nakanishi K., Higashino K. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J. Immunol. 1999, 162:1662.
20. Jacobson N.G., Szabo S.J., Weber-Nordt R.M., Zhong Z., Schreiber R.D., Darnell J.E., Murphy K.M. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med. 1995, 181:1755.
21. Johnson L.A., Goldfarb R.H., Mathew P.A. Regulation of IFN-gamma production following 2B4 activation in human NK cells. In Vivo 2000, 14:625.
22. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 2000, 18:621.
23. Kim K.E., Song H., Kim T.S., Yoon D., Kim C.W., Bang S.I., Hur D.Y., Park H., Cho D.H. Interleukin-18 is a critical factor for vascular endothelial growth factor-enhanced migration in human gastric cancer cell lines. Oncogene 2007, 26:1468.
24. Kim A., Son M., Kim K.I., Yang Y., Song E.Y., Lee H.G., Lim J.S. Elevation of intracellular cyclic AMP inhibits NF-kappaB-mediated thymosin beta4 expression in melanoma cells. Exp. Cell Res. 2009, 315:3325.
25. Kohno K., Kataoka J., Ohtsuki T., Suemoto Y., Okamoto I., Usui M., Ikeda M., Kurimoto M. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 1997, 158:1541.
26. Krzewski K., Chen X., Strominger J.L. WIP is essential for lytic granule polarization and NK cell cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2568.
27. Lee H.R., Yoon S.Y., Kang H.B., Park S., Kim K.E., Cho Y.H., Kim S., Kim C.W., Cho B.J., Lee W.J., Bang S.I., Park H., Cho D. Thymosin beta 4 enhances NK cell cytotoxicity mediated by ICAM-1. Immunol. Lett. 2009.
28. Lynch D.K., Winata S.C., Lyons R.J., Hughes W.E., Lehrbach G.M., Wasinger V., Corthals G., Cordwell S., Daly R.J. A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton. J. Biol. Chem. 2003, 278:21805.
29. Ma Y., Yang H., Qi J., Liu D., Xiong P., Xu Y., Feng W., Zheng G., Li P., Fang M., Tan Z., Zheng F., Gong F. CD2AP is indispensable to multistep cytotoxic process by NK cells. Mol. Immunol. 2010, 47:1074.
30. Mace E.M., Zhang J., Siminovitch K.A., Takei F. Elucidation of the integrin LFA-1-mediated signaling pathway of actin polarization in natural killer cells. Blood 2010.
31. Malinda K.M., Sidhu G.S., Mani H., Banaudha K., Maheshwari R.K., Goldstein A.L., Kleinman H.K. Thymosin beta4 accelerates wound healing. J. Invest. Dermatol. 1999, 113:364.
32. Marcenaro E., Dondero A., Moretta A. Multi-directional cross-regulation of NK cell function during innate immune responses. Transpl. Immunol. 2006, 17:16.
33. Muhl H., Pfeilschifter J. Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int. Immunopharmacol. 2003, 3:1247.
34. Oh S.Y., Song J.H., Gil J.E., Kim J.H., Yeom Y.I., Moon E.Y. ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance. Exp. Cell Res. 2006, 312:1651.
35. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88.
36. Papakonstanti E.A., Stournaras C. Cell responses regulated by early reorganization of actin cytoskeleton. FEBS Lett. 2008, 582:2120.
37. Pollard T.D., Blanchoin L., Mullins R.D. Actin dynamics. J. Cell Sci. 2001, 114:3.
38. Qiu P., Kurpakus-Wheater M., Sosne G. Matrix metalloproteinase activity is necessary for thymosin beta 4 promotion of epithelial cell migration. J. Cell. Physiol. 2007, 212:165.
39. Robertson M.J. Role of chemokines in the biology of natural killer cells. J. Leukoc. Biol. 2002, 71:173.
40. Rudin C.M., Engler P., Storb U. Differential splicing of thymosin beta 4 mRNA. J. Immunol. 1990, 144:4857.
41. Safer D., Elzinga M., Nachmias V.T. Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. J. Biol. Chem. 1991, 266:4029.
42. Scharton T.M., Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 1993, 178:567.
43. Schoenborn J.R., Wilson C.B. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 2007, 96:41.
44. Sosne G., Chan C.C., Thai K., Kennedy M., Szliter E.A., Hazlett L.D., Kleinman H.K. Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp. Eye Res. 2001, 72:605.
45. Srivastava D., Saxena A., Michael Dimaio J., Bock-Marquette I. Thymosin beta4 is cardioprotective after myocardial infarction. Ann. N. Y. Acad. Sci. 2007, 1112:161.
46. Sugawara I. Interleukin-18 (IL-18) and infectious diseases, with special emphasis on diseases induced by intracellular pathogens. Microbes Infect. 2000, 2:1257.
47. Tannenbaum C.S., Hamilton T.A. Immune-inflammatory mechanisms in IFNgamma-mediated anti-tumor activity. Semin. Cancer Biol. 2000, 10:113.
48. Tominaga K., Yoshimoto T., Torigoe K., Kurimoto M., Matsui K., Hada T., Okamura H., Nakanishi K. IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int. Immunol. 2000, 12:151.
49. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 1989, 47:187.
50. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 1995, 13:251.
51. Yarmola E.G., Somasundaram T., Boring T.A., Spector I., Bubb M.R. Actin-latrunculin A structure and function. Differential modulation of actin-binding protein function by latrunculin A. J. Biol. Chem. 2000, 275:28120.
52. Zhang Y., Feurino L.W., Zhai Q., Wang H., Fisher W.E., Chen C., Yao Q., Li M. Thymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation. Cancer Biol. Ther. 2008, 7:419.